Ledger.Open graph →
SEC Form D · Amendment · filed September 23, 2019

Navrogen, Inc

Offering
$3.2M
Sold
$3.2M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
PHILADELPHIA, PA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (6)

Edmund G. Zito · Chandler, AZExec · DirectorChristopher Tarr · Indianapolis, INExec · DirectorScott Conley · Austin, TXExecJosh Matthews · GRAND CAYMAN, Cayman IslandsExecMarc A. Cohen · ARLINGTON, VAExec · DirectorTodd Kaloudis · ARLINGTON, VAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗